bretylium has been researched along with Hyperoxia in 1 studies
bretylium: RN given refers to parent cpd
bretylium : A quaternary ammonium cation having 2-bromobenzyl, ethyl and two methyl groups attached to the nitrogen. It blocks noradrenaline release from the peripheral sympathetic nervous system, and is used in emergency medicine, cardiology, and other specialties for the acute management of ventricular tachycardia and ventricular fibrillation.
Hyperoxia: An abnormal increase in the amount of oxygen in the tissues and organs.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Yamazaki, F | 1 |
| Takahara, K | 1 |
| Sone, R | 1 |
| Johnson, JM | 1 |
1 other study available for bretylium and Hyperoxia
| Article | Year |
|---|---|
Influence of hyperoxia on skin vasomotor control in normothermic and heat-stressed humans.
Topics: Administration, Cutaneous; Adrenergic Agents; Adult; Blood Flow Velocity; Bretylium Compounds; Cyclo | 2007 |